Scientists from the National Institutes of Health and University of North Carolina at Chapel Hill have developed a new technique to detect breast cancer in a woman undergoing chemotherapy, which can also lead to detection of other cancers as well.
The study, published today in the Journal of Clinical Oncology, was funded by the National Cancer Institute and the National Institute on Aging.
The study’s authors say that the technique has the potential to dramatically reduce the number of false positive results associated with chemotherapy in the future.
“We are using this new ultrasound technique to screen for breast cancer early in the disease process, and it may ultimately provide hope for people who are waiting to see if they are at high risk of breast cancer,” said Dr. Paul Schurr, a researcher at the National Center for Complementary and Alternative Medicine at the NIH.
“We are also excited that the ultrasound technique will potentially reduce the rate of false positives in the years ahead.”
The ultrasound technique involves using an ultrasound sensor mounted on a small, flat device.
The sensor can detect a specific chemical that can be detected by an ultrasound device.
It can then be sent to a patient for treatment.
This is done with a standard ultrasound device that includes a scanning electron microscope and a laser.
In the future, the ultrasound method may also be used to monitor a patient’s health and detect tumors at a much more rapid rate.
The ultrasound study was conducted by researchers from the Institute for Cancer Research and the Department of Radiology at UNC Charlotte.
This research was supported by the Howard Hughes Medical Institute and by the NIH and the Cancer Prevention Research Program.
Follow the latest health and science news at National Institutes Of Health